AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.

Hormone receptor status can affect treatment decisions ...

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, offering a more precise first‑line.

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment decisions for breast cancer. In part three of CURE’s Breast Cancer Awareness ...

Two major studies are looking at moving sacituzumab govitecan earlier for metastatic triple-negative breast cancer.

Add Yahoo as a preferred source to see more of our stories on Google. A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found. The ...

Dr. Brian Czerniecki emphasized the importance of awareness about SERDs and clinical trials for ER-positive metastatic breast cancer. The event highlighted the significance of biomarkers and treatment ...

In "Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients ...

Triple Negative Breast Cancer (TNBC) is one of the most aggressive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

People living with metastatic breast cancer have more treatment options today than ever before. At Fred Hutch Cancer Center, we provide the latest in evidence-based care, including a wide range of ...

When actress Christina Applegate revealed her stage 1 breast cancer diagnosis in 2008, she made a bold decision to undergo a double mastectomy despite having cancer in only one breast. Years later, ...